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Survival motor neuron protein deficiency impairs
myotube formation by altering myogenic gene
expression and focal adhesion dynamics
Katherine V. Bricceno1,3, Tara Martinez4, Evgenia Leikina2, Stephanie Duguez6,
Terence A. Partridge6, Leonid V. Chernomordik2, Kenneth H. Fischbeck1,
Charlotte J. Sumner4,5 and Barrington G. Burnett1,7,∗
1

Received January 29, 2014; Revised and Accepted April 18, 2014

While spinal muscular atrophy (SMA) is characterized by motor neuron degeneration, it is unclear whether and
how much survival motor neuron (SMN) protein deficiency in muscle contributes to the pathophysiology of the
disease. There is increasing evidence from patients and SMA model organisms that SMN deficiency causes
intrinsic muscle defects. Here we investigated the role of SMN in muscle development using muscle cell lines
and primary myoblasts. Formation of multinucleate myotubes by SMN-deficient muscle cells is inhibited at a
stage preceding plasma membrane fusion. We found increased expression and reduced induction of key
muscle development factors, such as MyoD and myogenin, with differentiation of SMN-deficient cells. In
addition, SMN-deficient muscle cells had impaired cell migration and altered organization of focal adhesions
and the actin cytoskeleton. Partially restoring SMN inhibited the premature expression of muscle differentiation
markers, corrected the cytoskeletal abnormalities and improved myoblast fusion. These findings are consistent
with a role for SMN in myotube formation through effects on muscle differentiation and cell motility.

INTRODUCTION
Spinal muscular atrophy (SMA) is an autosomal recessive
disease characterized by proximal muscle weakness and degeneration of anterior horn cells (1). It is caused by mutation of the
SMN1 gene and deficiency of survival motor neuron (SMN)
protein (2). There is evidence to support a role for muscle
in the pathophysiology of SMA. SMN co-localizes with
a-actinin in myofibers, indicating a possible muscle-specific
function for SMN (3,4), and SMN-deficient myoblasts have
decreased fusion (5). In SMA mouse models, different fiber
groups are differentially affected by SMN deficiency (6 – 8).

Targeted knock-out experiments in mice have shown that
reducing SMN in muscle results in a dystrophic phenotype that
is corrected with SMN expression in muscle progenitor cells
(9,10). Both SMA patients and model mice have altered development of SMN-deficient muscle (11,12). Myotubes grown from
biopsies of patient muscle are smaller in size, consistent with
findings from the mouse model correlating muscle weakness
with fewer and smaller fibers. There is a delay in post-natal
muscle development that occurs in the absence of motor
neuron loss. Recent work with primary muscle cells has shown
that SMN has a role in myogenesis and that normal muscle differentiation requires adequate levels of SMN (13). Importantly,
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replacing SMN in SMA mouse muscle partially rescues muscle
cross-sectional area and myofiber diameter (14), further supporting a role for SMN in muscle growth and development.
In normal muscle development, proliferating myoblasts
differentiate, migrate and form myofibers through successive
fusion events. Many factors affect the fusion process, including
cell adhesion molecules, secreted molecules and their receptors,
and molecules that regulate actin cytoskeleton remodeling
[reviewed in (15)]. Among the cytoskeletal structures involved
in myoblast fusion are focal adhesions that directly bind to the
b1-integrins of the extracellular matrix (ECM) and to the actin
cytoskeleton. The focal adhesion complex is made up of
several proteins, including focal adhesion kinase, vinculin,
a-actinin and talin (16). Altered focal adhesion dynamics
disrupt cell migration and thus myoblast fusion.
In this study, we show that SMN-deficient muscle cells have a
fusion deficit and altered expression of differentiation markers,
which are partially rescued by restoration of SMN. We provide
evidence that talin-regulated focal adhesion dynamics are disrupted and are at least in part responsible for the fusion deficit.
Therefore, SMN deficiency may impair myoblast fusion
through defects in differentiation and cell motility.

RESULTS
SMA muscle cell lines have a fusion deficit that is rescued
by restoring SMN
It has previously been reported that SMN deficiency results in
reduced myoblast fusion into multinucleated myotubes (5,13).

To study the effects of SMN deficiency on myotube formation,
we established muscle cell lines from an SMA model mouse.
SMA delta 7 mice, which have the mouse Smn gene replaced
by human SMN2 and SMND7 (17), were crossed with mice overexpressing the H-2Kb-tsA58 (H2K) transgene (18), which
encodes a thermolabile mutant of the large T antigen that
allows the immortalization of the cells when grown at 338C in
the presence of g-interferon. When muscle cells from these
mice are switched to non-permissive conditions, 378C and
absence of g-interferon, they differentiate and form myotubes.
This method of generating conditionally immortal cell lines
has previously been used to generate cell lines from mouse
models of other muscle diseases, including limb-girdle muscular
dystrophy (19). We established monoclonal cell lines of immortalized SMN-deficient (seven lines) and wild-type myoblasts
(six lines) from the extensor digitorum longus (EDL) and tibialis
anterior (TA) muscles of P4 pups. All lines were purified to
remove fibroblasts and tested for myogenicity based on desmin
staining.
Following derivation of the muscle cell lines, we confirmed
that SMN levels were reduced by western blot (Supplementary
Material, Fig. S1) and then sought to confirm the previous
reports of a fusion deficit in SMN-deficient cells. We found
reduced fusion of SMN-deficient myoblasts into multinucleate
myotubes 6 days after initiating differentiation (Fig. 1A).
Overall, SMN-deficient myoblasts formed myotubes with
fewer nuclei (12% of multinucleated myotubes with four or
more nuclei) compared with wild-type muscle cells (35% of
multinucleated myotubes with four or more nuclei) (Fig. 1B).
We confirmed the fusion deficits in two SMA lines indicating
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Figure 1. SMN-deficient muscle cells have a fusion deficit. Muscle cells were differentiated for 6 days and stained for sarcomeric myosin (green) and desmin (red).
DAPI (blue) was added to label nuclei. Representative images are shown in (A). Scale bar, 100 mm. Arrows indicate myotube nuclei in each myotube. The number of
nuclei in myotubes divided by the total number of nuclei in myoblasts and myotubes, the fusion index, is quantified in A. Myotubes were defined as cells positive for
desmin and MF-20 with two or more nuclei. The percentage of myotubes with 2 –3, 4 –7 and 8 or more nuclei are quantified in (B). Nikon Elements software was used to
count cells and nuclei. Six experiments were done per cell line. The values represent mean + SEM (∗ P , 0.05, ∗∗ P , 0.01, ∗∗∗∗ P , 0.001).

Human Molecular Genetics, 2014

3

these effects were not limited to a single clone (Fig. 1A). To establish that the fusion deficit observed in SMN-deficient myoblasts was due to reduced SMN levels, we increased levels of
SMN by electroporating cDNA encoding full-length human
GFP-SMN into SMN-deficient cells (Supplementary Material,
Fig. S1). Assessments of GFP fluorescence showed that .90%
of fibers were electroporated. Increasing SMN levels rescued
the fusion deficit in the SMN-deficient cells (Fig. 2A) resulting
in myotubes with numbers of nuclei approaching those of wildtype myotubes (Fig. 2B); consistent with this result, we found

restoration of SMN increased the frequency of myotubes with
large numbers of nuclei (Supplementary Material, Fig. S2).
We next sought to confirm our findings in primary myoblasts
isolated from SMA model mice. We used conditional SMA mice
that express a Cre-inducible full-length Smn allele at the mouse
Smn locus with or without a Cre transgene controlled by the
MyoD promoter (SmnResMyoDCre) (14). The MyoD-Cre transgene allows expression of full-length SMN specifically in
muscle progenitor cells and myofibers (Supplementary Material,
Fig. S3). The Cre-positive mice have been shown to have
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Figure 2. Restoration of SMN rescues the fusion deficit in SMN-deficient muscle cells. Electroporation was used to introduce either human SMN or empty vector.
Muscle cells were allowed to recover in proliferation media for 6 h and then switched to differentiation conditions. The cells were differentiated for 6 days and
stained for sarcomeric myosin (green) and desmin (red). DAPI (blue) was added to label nuclei. Representative images are shown in (A). Scale bar, 100 mm. The
number of nuclei in myotubes divided by the total number of nuclei in myoblasts and myotubes, the fusion index, is quantified in A. Myotubes were defined as
cells positive for desmin and MF-20 with two or more nuclei. The percentage of myotubes with 2– 3, 4– 7 and 8 or more nuclei are quantified in (B). Nikon Elements
software was used to count cells and nuclei. Six experiments each were done for WT, SMN-deficient and SMN-deficient + SMN. Myoblasts were isolated from three
mice each for WT, SMA and SMA + MyoDCre and differentiated to myotubes for 4 days. Myotubes were stained for sarcomeric myosin (red). DAPI (blue) was added
to label nuclei. Representative images are shown in (C). Scale bar, 100 mm. The percentage of total nuclei in myotubes is quantified in C. Myotubes were defined as
cells positive for MF-20 with two or more nuclei. The percentage of myotubes with 2– 3, 4– 7 and 8 or more nuclei were counted by a blinded investigator and quantified
in (D). Values represent mean + SEM (∗ P , 0.05, ∗∗ P , 0.01, ∗∗∗ P , 0.001).
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full-length SMN mRNA and protein expression in muscle. We
cultured primary myoblasts from leg muscles of Cre-negative
and Cre-positive mice at P10. Using qRT-PCR, we verified
that full-length SMN levels were reduced in the Cre-negative
cells compared with wild-type cells and that the SMN levels
were corrected in Cre-positive cells as expected. We next
evaluated the ability of these primary myoblasts to fuse into
multinucleate myotubes and determined that, as with the
immortalized SMN-deficient cell lines, there was a reduced
number of multinucleated myotubes in myoblasts from SMA
MyoDCre-negative mice compared with WT mice. However,
myoblast fusion was substantially improved in SMA mice
expressing MyoDCre, with a number of nuclei per myotube
similar to wild-type myoblasts (Fig. 2C and D). Together these
findings indicate that SMN plays a role in myoblast fusion.
The local merger between myoblast plasma membranes and
subsequent expansion of nascent fusion connections are two
stages of myoblast fusion that are controlled by distinct protein
machineries (20). To test whether SMN deficiency blocks
myotube formation downstream from membrane merger, we
co-plated myoblasts labeled with the membrane probe DiO
and myoblasts labeled with membrane probe DiI in differentiation conditions. Merger of the membranes of differently
labeled cells generates co-labeled cells. As expected, for wildtype myoblasts, we observed the appearance of multinucleated
and co-labeled cells (Fig. 3A and B; arrowheads mark cells

co-labeled with both membrane probes). In contrast, in the
case of SMN-deficient myoblasts, we observed neither syncytium formation nor co-labeled cells. This finding indicates that
the lack of SMN inhibits myotube formation upstream of even
the earliest stages of myoblast fusion (schematic, Fig. 3C).
Proliferating SMA muscle cells have decreased expression
of Pax7 and increased expression of MyoD and myogenin
Given the reduced fusion of SMN-deficient myoblasts to form
multinucleate myotubes, we sought to determine the effects of
SMN deficiency on myoblast differentiation. Thus, we examined the levels of markers of muscle differentiation in
SMN-deficient cells compared with wild-type controls. First,
we investigated the expression levels of Pax7, a muscle progenitor cell marker; MyoD and myogenin, early differentiation
markers; and myosin heavy chain (MHC), a terminal muscle differentiation marker in undifferentiated, proliferating cells. Pax7
levels were reduced, whereas MyoD and myogenin levels were
elevated in the SMN-deficient cells compared with wild-type
cells (Fig. 4A and Supplementary Material, Fig. S4A). In addition, we found premature expression of MHC in SMN-deficient
cells. These data are consistent with a previous report that
SMN-deficient cells show premature muscle differentiation
(13). Increasing SMN levels in SMN-deficient myoblasts
restored MyoD and myogenin expression to wild-type levels
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Figure 3. SMN deficiency inhibits both lipid mixing (cell-to-cell redistribution of membrane probes) and syncytium (myotube) formation. The syncytium formation
assay reports only completed fusion events. In contrast, an appearance of co-labeled cells after co-incubation of differently labeled cells reveals even cell fusion events
stalled upstream of generation of multinucleated cells. (A) Left panel, fluorescence microscopy images of the wild-type (WT) myoblasts (top) and SMN-deficient
(SMN-deficient) myoblasts (bottom): DiI (red) and DiO (green). Arrowheads mark cells co-labeled with both membrane probes. A characteristic example of doublelabeled cell is also shown in the 2-fold enlargement of boxed region (left top corner of the panel). Note that by the time we scored fusion, DiI and DiO incorporated into
the plasma membrane are mostly internalized and label intracellular membranes. Right panel, phase contrast with nuclear staining (blue) images of the same cells.
Scale bar, 40 mm. (B) Fusion extents for the cells expressing SMN and for the SMN-deficient cells assayed as lipid mixing (red) and as syncytium formation (green). All
results are shown as mean + SEM (n . 3) (∗∗ P , 0.01). (C) Schematic of the sequence of events leading to myotube formation. SMN-deficient cells do not reach the
third stage of the myogenesis.
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but had no apparent effect on Pax7 expression (Fig. 4C and Supplementary Material, Fig. S4A). During myoblast differentiation, MyoD helps to induce expression of miR-206 and -486,
which further accelerate differentiation (21). Inhibition of
these microRNAs causes myoblasts to remain in a proliferative
state thus stalling differentiation. As we observed that MyoD expression is modulated by SMN, we next examined the expression
of miR-206 and -486 in wild-type and SMN-deficient myoblasts.
Compared with wild-type myoblasts, the expression of miR-206
and -486 was at least 9-fold higher in SMN-deficient cells
(Fig. 4B) but restored to wild-type levels after transient transfection with SMN.
We next examined the change in expression of muscle differentiation markers over 7 days following the initiation of

differentiation in SMN-deficient and wild-type cells. We
found that Pax7 levels remained lower in SMN-deficient cells
compared with levels in wild-type cells (Fig. 4C). Also, MyoD
and myogenin expression was elevated compared with wild-type
cells throughout differentiation. However, although MHC
levels were prematurely elevated in SMN-deficient cells, the
embryonic, perinatal and adult isoforms of MHC were significantly reduced (P , 0.05) at Day 7, as the cells approached
terminal differentiation stage (Fig. 4C). Pax7 decreased once differentiation began, consistent with its role as a progenitor cell
marker, and it was similarly reduced in the SMN-deficient and
wild-type cell lines over the course of differentiation (Supplementary Material, Fig. S4B). The expression of MyoD and myogenin peaked in both SMA and wild-type cell lines after 2 days of
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Figure 4. SMN-deficient muscle cells have increased expression of differentiation markers. (A) Proliferating muscle cells were collected and RNA isolated for
qRT-PCR following transfection with SMN or empty vector. (B) qRT-PCR analysis of miR-206 and -486 expression in proliferating wild-type and SMN-deficient
myoblast. (C) qRT-PCR following transfection with SMN or empty vector. Five time courses per genotype were run. The data are represented as the fold change
compared with wild type (black bars). Four time courses per genotype were run. Values represent mean + SEM (∗ P , 0.05, ∗∗ P , 0.01, ∗∗∗ P , 0.001).
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differentiation, but induction was lower in SMN-deficient cells
compared with wild-type cells (Supplementary Material,
Fig. S4B). Given the reduced induction of these early markers
of muscle differentiation, we sought to determine whether
MHC was also reduced. The level of induction of MHC was
similar in the SMN-deficient and wild-type cell lines for the
first 2 days of differentiation, after which MHC expression continued to increase in wild-type cells but remained unchanged in
SMN-deficient cells (Supplementary Material, Fig. S4B). Importantly, by 7 days of differentiation, SMN-deficient myoblasts
have dramatically reduced expression of terminal differentiation
markers, which fits with the observed fusion deficit.

turnover (26– 29). Vinculin cycles between a closed, inactive
state in the cytoplasm and an open, active state at focal adhesions
where it stabilizes focal complexes (30).We examined the distribution of vinculin in SMN-deficient and wild-type cells by immunocytochemistry. In SMN-deficient cells, we found that
vinculin is present at focal adhesions around the cell periphery
(Fig. 5C), but there is decreased staining in the cell body compared with wild-type cells. These data suggest that the reduced
migration of SMN-deficient cells could be due to persistence
of vinculin at the cell periphery.
Cleavage of talin is reduced in SMA muscle cells

To differentiate and fuse, proliferating myoblasts and satellite
cells must migrate, align and establish stable cell – cell contacts.
Cell migration is thus a fundamental cellular function during
skeletal muscle development. We investigated whether altered
cytoskeletal dynamics and cell migration contribute to the
fusion deficit observed in SMN-deficient cells. To determine
whether SMN deficiency affects muscle cell migration, we
examined cell motility by clearing an area of cultured myoblasts
and counting the number of cells migrating into the denuded
region after 24 h. We found that 75% fewer SMN-deficient
cells migrated into the denuded region compared with wild-type
cells, indicating that cell migration is compromised (Fig. 5A).
Restoration of SMN resulted in improved migration with twice
the number of cells migrating into the denuded region.
Cell migration is a result of a number of molecular and cellular
events, with reorganization of the actin cytoskeleton foremost
among them (22). Cell spreading and migration are driven by
actin polymerization and the presence of actin stress fibers.
Given the reduced cell migration of SMN-deficient cells, we
explored whether the actin cytoskeleton is altered in these
cells. We plated myoblasts on chamber slides and observed the
cytoskeleton with fluorescence microscopy, using Alexa Fluor
555-labeled phalloidin to visualize actin fibers. We found that
SMN-deficient cells had a disorganized actin cytoskeleton
with almost complete absence of central stress fibers (Fig. 5B).
In addition, these cells had increased numbers of filopodia, protrusions and thin projections around the cell perimeter compared
with wild-type cells (Fig. 5B, yellow arrows). Restoration of
SMN resulted in fewer protrusions around the perimeter and
more central stress fibers, similar to wild-type cells (Fig. 5B,
white arrows).
Focal adhesions are sites of contact between the cell surface
and the ECM, where the associated stress fibers terminate (23).
They consist of structural proteins that link integrins to the
actin cytoskeleton and signaling proteins that transduce a
range of adhesion-dependent processes. Focal adhesions thus
serve both structural and signaling functions. The structural
role is to connect actin stress fibers to the ECM by the association
of integrins with adaptor proteins such as vinculin, talin and
a-actinin. Vinculin is an actin-binding protein involved in the
mechanical coupling between the actin cytoskeleton and the
ECM (24,25). Reduced vinculin expression results in increased
cell spreading and cell migration, indicating a role for vinculin in
the negative regulation of cell motility and focal adhesion

Talins 1 and 2 connect integrins to the actin cytoskeleton and are
required for myoblast migration and fusion (31). Talin interacts
with both focal adhesion proteins and actin filaments (16), and
cleavage of talin regulates the turnover of focal adhesions. In
the absence of talin cleavage, vinculin-positive focal adhesions
are lost from the cell body and stabilized at the perimeter (32),
as we observed in SMN-deficient cells. We thus examined
talin protein cleavage by western blot analysis. We found that
talin cleavage was reduced by .50% in SMN-deficient cells
compared with wild-type controls (Fig. 6A). This finding
prompted us to examine the turnover of enhanced green fluorescent protein (EGFP)—talin at protrusive structures in spreading
muscle cells. To assess the effects of SMN deficiency on talin
dynamics, we expressed talin in wild-type and SMN-deficient
myoblasts. Time-lapse analysis of GFP-talin localization
showed that talin persisted almost twice as long in adhesion
complexes in SMN-deficient cells compared with wild-type
cells (Fig. 6B and C). Together these data suggest that SMN deficiency results in reduced motility of myoblasts concomitant
with reduced talin cleavage and increased persistence of talin
and vinculin in focal adhesions (Fig. 6E). As constant focal
adhesion assembly and disassembly are required for cell migration, these differences could account for the fusion deficit of
SMN-deficient myoblasts.

DISCUSSION
In this study, we sought to answer two questions: does SMN
deficiency cause a myoblast fusion deficit, and what are the
molecular mechanisms underlying the change in fusion?
We show that a smaller percentage of SMN-deficient myoblasts
are incorporated into multinucleate myotubes, consistent
with the fusion deficit reported by other groups (5,13,33).
We extended these previous studies by showing that this
fusion deficit can be rescued by restoring SMN, which indicates
that SMN plays an important role in this cellular activity. We
further demonstrate that SMN deficiency impedes the early
stages of myoblast fusion before the cell membranes merge
and that SMN-dependent alterations in the actin cytoskeleton
and in focal adhesion dynamics may be contributing to the
fusion deficit.
To better understand the mechanism behind the fusion
defect in SMN-deficient cells, we looked for differences in
the expression of markers of muscle differentiation. MyoD and
myogenin are members of a family of muscle regulatory basic
helix-loop-helix transcription factors that bind to regulatory
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SMA muscle cells have reduced motility and altered
actin cytoskeleton
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Figure 5. SMN-deficient muscle cells have altered motility and actin fiber organization. (A) After 1 day in differentiation conditions, confluent muscle cells were
scraped off with a cell scraper and the media was replaced. The number of cells that moved into the denuded area after 24 h was counted. The data represent the
average of at least three fields per experiment from four experiments. The data are shown as percentages of the wild-type average. Representative images are
shown at left. (B) Representative images of undifferentiated muscle cells stained for F-actin (red) showing protrusions (yellow arrows) and stress fibers (white
arrows). Muscle cells were transfected with GFP-SMN (green) and stained for F-actin (red). At least 50 cells per condition were counted for the presence of
central stress fibers and percent cells with at least one central fiber calculated and graphed. (C) Representative images of undifferentiated muscle cells were
stained for vinculin (green). Smaller panels are magnified images of adhesions. The values represent mean + SEM (∗ P , 0.05, ∗∗ P , 0.01, ∗∗∗ P , 0.001).
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Figure 6. SMN-deficient muscle cells have decreased cleavage and increased retention of talin. (A) Undifferentiated muscled cells were collected and cell lysates
prepared for western blot. Data are quantified as the ratio of cleaved to full-length talin. (B) Undifferentiated muscle cells were electroporated with human GFP-talin
construct and were analyzed by time-lapse microscopy. Duration measurements were made by counting the time elapsed between the first and last frames in which an
adhesion was observed. (C) Quantification of data in B. At least 20 adhesions were counted for each genotype. Values represent mean + SEM (∗ P , 0.05, ∗∗ P , 0.01,
∗∗∗
P , 0.001). (D) Schematic representation of proposed focal adhesion dynamics in SMN-deficient cells.
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this, recent work shows that early expression of SMN in muscle
tissue, driven by the MyoD promoter (active at E9.75), improves
survival and motor function (14).
The phenotype of mice with muscle-specific deletion of exon
7 in murine Smn supports the role of SMN in muscle development. Deletion of Smn exon 7 in actively dividing muscle precursors resulted in muscle necrosis, motor paralysis and earlier
death than in mice with exon 7 deleted later, in fused myotubes
(9). In response to muscle damage, regeneration was impaired in
mice with exon 7 deleted in muscle precursor cells and fused
myotubes. In contrast, regeneration in mice with exon 7
deleted in myotubes was not significantly different from controls. Amelioration of muscle pathology in SMA may depend
on correcting levels of SMN in muscle early in development.
The data presented here support a mechanism for SMN in
early muscle development, specifically in regulating myogenic
gene expression and actin and focal adhesion dynamics involved
in cell migration. It is unclear whether the early dysregulation of
myogenic programing subsequently leads to the alterations in
cytoskeletal dynamics or whether these are independent events
that in parallel contribute to deficits in myoblast fusion.
Improved understanding of the normal function of SMN in
muscle and other tissues will allow us to identify critical functions of SMN that when deficient may contribute to the SMA
phenotype and therefore be targets for therapeutic intervention.

MATERIAL AND METHODS
H2K-SMA mice
Experiments were approved by the NINDS Animal Care and Use
Committee. H-2Kb-tsA58 (H2K)-SMA mice were purchased
from Jackson Laboratories, stock number 006553. An
H2K-SMA mouse breeder colony was maintained as described
in (43).
SMA MyoDCre primary myoblasts
SMA MyoDCre mice have been previously described (14).
Briefly, SMA mice expressing an Smn Cre-inducible allele
and two copies of SMN2 and SMND7 alleles (SmnRes/
SMN2+/+/ SMND7+/+) were bred to MyoDCre-expressing
mice. Cre-positive SMA mice were those with the inducible
Smn allele in a homozygous state (SmnRes/Res/SMN2+/+/
SMND7+/+) in the presence of Cre. Cre-negative SMA mice
were those with the inducible Smn allele in a homozygous
state (SmnRes/Res/SMN2+/+/ SMND7+/+) in the absence
of Cre.
Satellite cell isolation
Hind limb muscles were isolated from P10 mice and put into
plain Dulbecco’s Modified Eagle Medium (DMEM) in 6-well
plate. The muscles were minced with a sterile razor blade and
incubated at 378C in 2 ml of 0.2% type II collagenase and displaced for 1 h 30 min into the incubation; the samples are
pipetted up and down carefully to help in digestion of the
muscle. After 1 h of incubation, samples were passed through
a 40-mM cell strainer into a 50-ml conical tube, and 3 ml of satellite cell media was added [satellite cell media: DMEM, 5%
L-glutamine, 10% FBS (Life Technologies, Grand Island, NY,
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regions, E-boxes, in many genes expressed in skeletal muscle
(34) and to their own regulatory sequences, creating a positive
feedback loop that drives cells toward a myogenic fate (35,36).
Changes in the expression or activity of these transcription
factors are thus critical to muscle differentiation (35,37). The
level of myogenin was higher in proliferating SMN-deficient
cells, and the cells have reduced induction of this marker when
switched to differentiation conditions. It is unclear whether premature expression of myogenin affects myotube formation or if
the level of induction is more important than the absolute levels
of myogenin. Given that SMN-deficient cells have reduced
myotube formation in the presence of elevated levels of myogenin, it is possible that impaired myotube formation in SMNdeficient cell occurs because of decreased induction rather
than differences in the absolute expression levels of MyoD and
myogenin. Nevertheless, altered expression of these early
markers of differentiation led to potentially inadequate levels
of the terminal differentiation marker MHC in SMN-deficient
cells, suggesting early dysregulation of muscle differentiation.
A more proximate cause of the reduced fusion of
SMN-deficient myoblasts may be impairment in the transmission of mechanical forces needed for cells to migrate and fuse.
The findings presented here suggest that SMN deficiency
results in decreased cell migration, which could lead to a decrease in myoblast fusion. We also found that SMN-deficient
myoblasts have decreased talin cleavage and retention of talinpositive focal adhesions, with increased concentration of vinculin at the cell periphery. Talin mediates the interaction between
integrins and the actin cytoskeleton, and we found altered actin
organization in SMA muscle cells. Focal adhesion turnover and
actin dynamics are both involved in cell motility and migration,
and SMN-deficient cells have altered focal adhesion dynamics
and central actin fiber localization compared with wild-type
cells. Overall, these data show that SMA muscle cells have
SMN-dependent alterations in expression of factors critical for
muscle development and cytoskeletal defects that are associated
with reduced cell motility.
An increasing body of evidence suggests that SMA muscle
pathology could be due in part to deficiency of SMN in
muscle. In vitro experiments showed that SMA patient muscle
can be successfully innervated with embryonic rat spinal cord
explants, but the innervated myofibers undergo degeneration
after 1 – 3 weeks; such as was not observed in cultures of
muscle from aged-matched, healthy controls (38,39). Later
studies showed that muscle cell lines deficient in SMN have
decreased proliferation and fusion (5), and studies in mouse
models of SMA found altered morphology and neuromuscular
transmission (6,40,41). Together, these findings suggest that
while motor neuron degeneration is characteristic of SMA, a
primary deficit in muscle may be contributing to the pathology.
In a study of cell autonomy in SMA, Burghes and colleagues
over-expressed SMN in striated muscle with a skeletal actin promoter and did not find a significant improvement in the lifespan
of SMA model mice (42). Overexpression of SMN in neuronal
cells extensively extended the lifespan of the mice. However,
the muscle-specific skeletal actin promoter drives SMN expression only in post-mitotic myotubes, not proliferating myoblasts
or satellite cells. If SMN indeed has a role in early muscle development, then SMN expression in proliferating cells would likely
be needed to see improvement in the phenotype. Consistent with
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H2K-SMA cell lines
To generate H2K-SMA cell lines, P4 mice were sacrificed and
myofibers were isolated from the EDL and TA muscles as
described in (44). To purify the cell population, the cells were
pre-plated on a Petri dish and incubated at room temperature
for 20 min. Fibroblasts quickly attach to the plastic, whereas
myoblasts do not attach as quickly to plastic and remain in solution. After incubation, the supernatant was transferred to a
Matrigel-coated culture dish. The cells were allowed to grow
(see proliferation conditions described later) until they were at
least 50% confluent, and then the pre-plating process was
repeated. The cells were pre-plated at least three times and
then tested for myogenicity based on staining for desmin as
described in (44). Once established, the muscle cell lines were
maintained in proliferation media [DMEM with pyruvate and
glutamine (Life Technologies), 20% FBS, 2% chick embryo
extract (Accurate Chemical, Westbury, NY, USA), 20 U/ml
g-interferon (Millipore, Billerica, MA, USA), 1× penicillin
and streptomycin mixture (Life Technologies)] on culture
dishes coated with Matrigel (BD Biosciences, San Jose, CA,
USA) at 338C and 10% CO2. For differentiation into myotubes,
the cells were switched to differentiation media [DMEM with
pyruvate and glutamine (Life Technologies), 5% horse serum
(Life Technologies), 1× penicillin and streptomycin mixture
(Life Technologies)] and cultured at 378C and 5% CO2.
Myoblast fusion assays
Muscle cells were grown on Matrigel-coated plastic in differentiation conditions for 6 days. The cells were fixed in 4% formalin
at 378C for 15 min, washed in phosphate-buffered saline (PBS)
and blocked in 0.5% Triton X-100, 20% goat serum and 2%
bovine serum albumin in Tris-buffered saline with 0.1% Triton
X (TBST). The cells were immunostained with mouse antisarcomeric myosin (1:200; MF-20, Developmental Studies

Hybridoma Bank, Iowa City, IA, USA), rabbit anti-desmin
(1:200; Abcam, Cambridge, MA, USA) in 0.2% Triton X-100,
2% goat serum and 2% bovine serum albumin in TBST. Cells
were washed in TBST and incubated in goat anti-mouse Alexa
Fluor 488 (1:200; Life Technologies,), goat anti-rabbit Alexa
Flour 555 (1:200; Life Technologies) and DAPI in the same solution as used for the primary antibodies. Following the incubations, the cells were washed in TBST. Pictures were taken with a
Nikon Eclipse Ti microscope using Nikon Elements software.
For the fusion index, the investigator taking the pictures did
not know the genotype of the cells. Nikon Elements software
was used to count cells and nuclei. Myotubes were defined as
cells positive for desmin and MF-20 with two or more nuclei.
The percentage of nuclei in myotubes, or fusion index, was calculated as the number of nuclei in myotubes divided by the total
number of nuclei in myoblasts and myotubes.
Membrane merger assay
Cell-to-cell fusion starts with a local merger between the cell
membranes. To detect fusion events in which nascent membrane
connections between the cells did not expand to yield multinucleated cells, we co-plated differently labeled cells and
assayed fusion as the appearance of co-labeled cells. Twentyfour hours after placement in differentiation medium, the cells
were labeled as recommended by the manufacturer with one of
the two fluorescent lipophilic tracers Vybrant DiI and Vybrant
DiO (Molecular Probes, Inc., Eugene, OR, USA, V22885 and
V-22886, respectively, 1:300 dilution). Differently labeled
cells were co-plated. Fusion was scored 24 h later (20). To quantify the efficiency of myoblast fusion, we fixed the cells in
phosphate-buffered, 10% w/v formalin solution (#15740; Electron Microscopy Sciences). Cell nuclei were labeled with
Hoechst-33342 (Molecular Probes, Inc.). We prepared and analyzed images using Image J (National Institutes of Health). For
each condition, we took images of 10 randomly chosen fields
of view (greater than 600 nuclei per condition). We detected
early stages of cell fusion as the redistribution of the membrane
probes between differently labeled cells and presented the data
as the percentage of nuclei in co-labeled cells (including both
mono- and multi-nucleated cells) compared with the total
number of nuclei in the field of view. The efficiency of
myotube formation was quantified as the percentage of cell
nuclei present in myotubes normalized to the total number of
cell nuclei.
RNA isolation
Total RNA was isolated from muscle cells using Trizol (Life Technologies), and the RNeasy kit (Qiagen, Germantown, MD, USA)
was used to purify the RNA according to the manufacturer’s
instructions (45). One microgram of RNA was converted to
cDNA using the High Capacity cDNA Reverse Transcription kit
(Life Technologies), following the manufacturer’s instructions.
Gene expression was determined by qRT-PCR using TaqMan
reagents (Life Technologies). Primers were MyoD (TaqMan
assay Mm00440387_m1), Myh3 (TaqMan assay Mm01332452_
m1), Myh8 (TaqMan assay Mm01329494_m1), Myh7 (TaqMan
assay Mm01319006_g1), Myogenin (TaqMan assay
Mm00446194_m1), Pax7 (Mm00834079_m1) and Pgk1
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USA), 20% fetal bovine serum (Atlanta Biologicals, Lawrenceville, GA, USA) and 5% 1× penicillin and streptomycin mixture
(Life Technologies)]. The samples were centrifuged for 5 min at
1500 rpm. The supernatant was removed, and pellet was resuspended in 2.5 ml satellite cell media and plated onto one well
of a 6-well plate. One hour after plating, the samples were carefully removed from the 6-well plate and re-plated on a new
6-well plate (pre-plating). Every 24 h for the next 3 days, the
samples were pre-plated on a new 6-well plate. Twenty-four
hours after last pre-plate, a new 6-well plate was coated with
Matrigel (BD Bioscience, 1:5 dilution in plain DMEM). The
samples were then plated onto coated 6-well plate for growth.
Satellite cell differentiation: satellite cells were removed from
6-well plate using 0.05% trypsin for 3 min at 378C. The cells
were resuspended in 5 ml satellite cell media and centrifuged
at 1500 rpm for 5 min. The pellet was resuspended in 1 ml satellite cell media, and the cells were counted using a standard hemocytometer. For differentiation, the satellite cells were plated on
Matrigel-coated 96-well plates at a density of 25 000 cells per
well. One hour after plating, the media was removed and
replaced with differentiation media (DMEM, 5% L-glutamine,
2% FBS, 5% 1× penicillin and streptomycin mixture) and differentiated for 4 days.
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(Mm00435617_m1). Myh3, Myh8 and Myh7 are the embryonic,
perinatal and adult isoforms of MHC, respectively. Transcript
levels were quantified by threshold cycle values using phosphoglycerate kinase 1 as a control. For each gene, values were normalized
to unaffected cells.
Western blots

Electroporation of H2K cells
DNA was transfected into H2K-SMA cells by electroporation
using the Amaxa Cell Line Nucleofection Kit V (Lonza,
Valais, Switzerland) following the manufacturer’s instructions
with the following modifications for the H2K cells. For each
transfection, 500 000 cells were used. Following transfection,
the cells were returned to proliferation conditions (mentioned
earlier). If myotubes were required for the experiment, the
cells were switched to differentiation conditions once they
adhered to the dish 6 h post-electroporation. Two micrograms
of GFP-SMN or GFP empty vector or GFP-talin (Addgene,
Cambridge, MA, USA) was used for each transfection. For
fusion assays, myc constructs described in (46) were used.
Cell migration assays
Muscle cells were grown on Matrigel-coated plastic in differentiation conditions for 1 day. An area of the well was denuded.
The cells were washed in PBS and fresh media added. The
cells were allowed to grow for an additional 24 h in differentiation conditions. The cells were fixed in 4% formalin at 378C
for 15 min, washed in TBST, and the number of cells that
moved into the denuded area was counted. Pictures were taken
with a Nikon Eclipse Ti microscope using Nikon Elements
software. The investigator taking the pictures did not know the
genotype of the cells.
Immunostaining
Muscle cells were grown in proliferation conditions for 2 days
on glass chamber slides coated with poly-D-lysine (PDL)
(Sigma). One day before plating, the slides were coated overnight at 378C with 50 mg/ml of PDL in PBS. The next day, the
slides were washed with PBS and dried for 1 h at 378C. The
slides were washed once with DMEM before plating the cells.
The cells were fixed in 4% cold paraformaldehyde in PBS for
30 min at 48C, washed in PBS and blocked in 0.3% Triton

X-100 and 10% goat serum in PBS. The cells were immunostained with Alexa Fluor Phalloidin 555 (1:50, Life Technologies) or mouse anti-vinculin (1:400, Sigma) in 0.1% Triton X100 and 5% goat serum in PBS. The cells were washed in
TBST and incubated in goat anti-mouse Alexa Fluor 488
(1:200; Life Technologies) (vinculin only) and DAPI in the
same solution as used for the primary antibodies. Following
the incubations, the cells were washed in PBST. Pictures were
taken on a Leica TCS SP5 II confocal microscope using Leica
LAS AF software. The number of stress fiber per cell was determined by counting cells with at least one central stress fiber in at
least 25 stained cells per condition.
Time-lapse microscopy
Time-lapse fluorescence imaging of live cells was done with a
63× objective on a Leica TCS SP5 II confocal microscope
using Leica LAS AF software. The cells were transfected (mentioned earlier) with GFP-talin and grown on glass-bottom dishes
coated with PDL (Sigma). One day before plating, the slides
were coated overnight at 378C with 50 mg/ml of PDL in PBS.
The next day, the slides were washed with PBS and dried for
1 h at 378C. The slides were washed once with DMEM before
plating the cells. Fluorescent images were captured every
2 min for 2 h. Time-lapse sequences were used to determine
the duration of focal adhesions by counting the amount of time
elapsed between the first and last frame when an adhesion was
observed. For each cell type, at least 20 individual adhesions
were counted in five separate cells by a blinded evaluator.
Statistical analysis
Data are presented as mean + standard error. T-tests were performed using GraphPad Prisim 5 software (GraphPad Software)
with significance set at P , 0.05.
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